Search results
Results from the WOW.Com Content Network
[1] [2] In 2007 exports of pharmaceutical products from the UK totalled £14.6 billion, creating a trade surplus in pharmaceutical products of £4.3 billion. [3] UK Pharmaceutical employment of 73,000 in 2017 [4] compares to 114,000 as of 2015 in Germany, [5] 92,000 as of 2014 in France [6] and 723,000 in the European Union as a whole. [6]
Actelion – Actelion Pharmaceuticals UK Ltd; Aesica pharmaceuticals - Aesica Queenborough Ltd; Air Products – Air Products plc; Alcon – Alcon Laboratories (UK) Ltd; ALK-Abelló – ALK-Abelló (UK) Ltd; Allergan – Allergan Ltd; Alpharma – King Pharmaceuticals; Almus Pharmaceuticals - Walgreens Boots Alliance; Altana – Altana Pharma ...
The Association of the British Pharmaceutical Industry (ABPI) is the trade association for over 120 companies in the UK producing prescription medicines for humans, founded in 1891. [1] It is the British equivalent of America's PhRMA ; however, the member companies research, develop, manufacture and supply medicines prescribed for the National ...
It provides daily news and analysis on the biotechnology and pharmaceutical industry including areas such as policy & regulation, business news, research & development, generics, drug delivery, and clinical trials. In 2022, Informa sold its Pharma Intelligence division, including Scrip, to Warburg Pincus. [4] The business was renamed Citeline.
The British Generic Manufacturers Association is a trade association for the British generic drug industry. It has offices in the City of London. Mark Samuels is the Chief Executive of the association and also of the British Biosimilars Association. [1] The current Chair is Diane DiGangi Trench, head of Sandoz UK. [2]
This page was last edited on 17 February 2024, at 21:14 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
The Pharmaceutical Price Regulation Scheme (PPRS) is the mechanism used by the UK Department of Health to ensure that the NHS has access to good quality branded medicines at reasonable prices. It involves a non-contractual agreement between the UK Department of Health and The Association of the British Pharmaceutical Industry (ABPI). The scheme ...
The British Pharmacopoeia is an important statutory component in the control of medicines, which complements and assists the licensing and inspection processes of the UK's Medicines and Healthcare products Regulatory Agency (MHRA). Together with the British National Formulary (BNF), the British Pharmacopoeia defines the UK's pharmaceutical ...